Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria

Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery diseas...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Neira V,Víctor, Potthoff N,Marcelo, Quiñiñir S,Luis, López R,Gabriel, Stockins F,Benjamín, Castillo B,Carlos, Lanas Z,Fernando
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2013
Materias:	Coronary artery disease Secondary prevention
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872013000700006
record_format	dspace
spelling	oai:scielo:S0034-988720130007000062013-12-17Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronariaNeira V,VíctorPotthoff N,MarceloQuiñiñir S,LuisLópez R,GabrielStockins F,BenjamínCastillo B,CarlosLanas Z,Fernando Coronary artery disease Secondary prevention Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%> were using aspirin, 78%> statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using β - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.7 20132013-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006es10.4067/S0034-98872013000700006
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Coronary artery disease Secondary prevention
spellingShingle	Coronary artery disease Secondary prevention Neira V,Víctor Potthoff N,Marcelo Quiñiñir S,Luis López R,Gabriel Stockins F,Benjamín Castillo B,Carlos Lanas Z,Fernando Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
description	Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%> were using aspirin, 78%> statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using β - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.
author	Neira V,Víctor Potthoff N,Marcelo Quiñiñir S,Luis López R,Gabriel Stockins F,Benjamín Castillo B,Carlos Lanas Z,Fernando
author_facet	Neira V,Víctor Potthoff N,Marcelo Quiñiñir S,Luis López R,Gabriel Stockins F,Benjamín Castillo B,Carlos Lanas Z,Fernando
author_sort	Neira V,Víctor
title	Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_short	Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_full	Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_fullStr	Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_full_unstemmed	Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_sort	logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
publisher	Sociedad Médica de Santiago
publishDate	2013
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006
work_keys_str_mv	AT neiravvictor logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT potthoffnmarcelo logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT quininirsluis logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT lopezrgabriel logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT stockinsfbenjamin logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT castillobcarlos logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria AT lanaszfernando logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
_version_	1718436699527184384

Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria

Ejemplares similares